| Product Name: | Tafluprost |
| Synonyms: | Isopropyl (5Z)-7-{(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoate |
| CAS No: | 209860-87-7 |
| Chemical Formula: | C₂₅H₃₄F₂O₅ |
| Grade: | USP/IP/IH |
| Appearance: | Colorless to pale yellow liquid. |
| Molar Mass: | 452.6 g/mol |
| Solubility: | Insoluble in water but soluble in organic solvents such as ethanol and acetonitrile. |
Description
Chemignition is a leading manufacturer and exporter of Tafluprost Active Pharmaceutical Ingredients (API) worldwide. The company adheres to strict Quality Management Systems (QMS) to ensure compliance with Good Manufacturing Practices (cGMPs). This commitment to quality and regulatory standards guarantees that Chemignition produces Tafluprost of the highest quality and efficacy.
Tafluprost primarily treats eye diseases such as glaucoma and ocular hypertension. It reduces intraocular pressure (IOP) and helps prevent damage to the optic nerve, which is crucial for vision. Tafluprost enhances fluid drainage from the eye, addressing abnormalities in the eye’s drainage system and preventing excessive pressure that can lead to vision loss.
During the manufacturing of Active Pharmaceutical Ingredients (API) and specialty chemicals, Chemignition employs various processes, including dissolution, charcoalization, filtration, leaching, extraction, crystallization, and purification.
The U.S. Food and Drug Administration (FDA) approved Tafluprost in 2012 for treating elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension. It is marketed under various brand names, including Zioptan, and is considered a valuable addition to the therapeutic options available for managing these conditions.
Storage Condition: Pack Tafluprost in tightly closed vials, maintain it in a sealed container, and store it at a temperature between -20°C and -10°C.